Denver, CO, August 30, 2014 --(PR.com
)-- The Colorado BioScience Association (CBSA) has confirmed three of Colorado’s top CEOs for its ‘Colorado Companies: From Concept to Market’ presentation at the 2014 BioWest Conference & Expo. Participating CEOs include Bill Aldrich, EndoShape; David Brunel, Biodesix; and Byron Hewett, SomaLogic.
The announcement is made by CBSA President & CEO April Giles, who says, “Bringing a product to market is becoming an increasingly difficult task. BioWest attendees will have the unique opportunity to share in the personal insights of three of our state’s most accomplished CEOs, detailing how they lead their teams to successfully cross the finish line.”
The 2014 BioWest Conference, is September 10, at the Marriott City Center, 1701 California Street, Denver. “Colorado Companies: From Concept to Market” is scheduled for 9:45-10:45 am.
More about the participating CEOs in the ‘Concept to Market’ session:
Bill Aldrich, CEO, EndoShape – Boulder
Mr. Aldrich has held executive and engineering positions at Ampex, BioTrack, CVIS, Cartesian Data, CardioThoracic Systems, Integrated Vascular Systems and, most recently, at EndoVx, which he founded and raised $5M in venture financing. For more information, visit: http://www.endoshape.com.
David Brunel, CEO, Biodesix– Boulder
Mr. Brunel has been involved in enterprise software for over 25 years and has been involved in molecular diagnostics since 2000. Mr. Brunel was a founder and CEO of Unidata, Inc. when it merged with Vmark Software to create Ardent Software, Inc., where he was President and COO. For more information, visit: http://www.biodesix.com.
Byron Hewett, CEO, SomaLogic– Boulder
Mr. Hewett joined SomaLogic in December, 2013, most recently serving as Chairman and CEO at BioBehavioral Diagnostics, Inc. He previously held executive positions with Immunicon Corporation, Qiagen; Bayer Diagnostics, Chiron Diagnostics and Abbott Laboratories. For more information, visit: http://www.somalogic.com.
“Colorado Companies: From Concept to Market” will be moderated by Jim Langley from The Mead Consulting Group, sponsoring the segment. For more information, visit: http://www.meadconsultinggroup.com.
New this year: C-Level Unplugged
In addition to the CEO panel event, BioWest 2014 is also debuting two sessions of “C-Level Unplugged: Conversations with top level leadership.” The afternoon session, 1:15 – 1:30 pm will feature a fast-paced interview on the Exhibit Hall stage with Shahriar (Shar) Matin, Chief Operating Officer of Spectranetics. The C-Level speaker for the morning session, 9:20 – 9:35 am is still being confirmed.
About BioWest 2014 | September 10, 2014 | #BioWest2014
The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs.
The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 pm) sponsored by Dohmen and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; sponsored by the Fitzsimons Redevelopment Authority and Russell Slifer, Director, United States Patent & Trademark, Rocky Mountain Regional Office sponsored by Sheridan Ross PC. The full schedule of the day’s events is found at: http://www.cobioscience.com/biowest/schedule.
Registration is now open at http://www.CoBioScience.com/BioWest. Rates for members start at $325 and $375 for non-members and passes for the expo hall & reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations. BioWest 2014 also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees. Conference Sponsors include: AdvaMed, Amgen, BIO, BioFrontiers Institute, DePuy Synthes, DaVita Clinical Research, Dorsey & Whitney LLP, Dohmen Life Science Services, EY, Evergreen Research, Fitzsimons Redevelopment Authority, Fisher Scientific, Metro Denver EDC, The Mead Consulting Group, Quintiles, SomaLogic, Sheridan Ross PC, Square 1 Bank, Silicon Valley Bank, TerumoBCT
About Colorado BioScience Association
CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com.
Mae Desaire, Director of Marketing, Colorado BioScience Association - http://www.cobioscience.com – 720-382-5918, firstname.lastname@example.org
Maggie Chamberlin Holben, APR, Absolutely Public Relations - http://www.absolutelypr.com - 303-984-9801, email@example.com